The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The protein encoded by A0A2R9CAF4 in Pan paniscus (bonobo) is the ortholog of human SLC26A11 (solute carrier family 26 member 11), also known as KBAT (kidney and brain anion transporter) or SUT1. While no direct literature exists for this specific bonobo protein, the UniProt annotation correctly identifies it as a sodium-independent sulfate anion transporter belonging to the SLC26/SulP transporter family. High sequence conservation among primate orthologs allows us to confidently infer the bonobo protein's function from extensive recent research on human and mammalian SLC26A11 (kuhn2025slc26a11isan pages 1-4, bungertplumke2024oligomerizationandcellular pages 1-3, lee2024chloridemultipleanionexchanger pages 1-2).
Recent breakthrough structural and functional studies from 2024-2025 have resolved the long-standing controversy about SLC26A11 function, demonstrating that it is a dual-function protein capable of operating as both a secondary active transporter and an anion channel (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14).
As a transporter, SLC26A11 functions as an electroneutral proton:sulfate/chloride exchanger (kuhn2025slc26a11isan pages 1-4). Reconstitution experiments with purified human SLC26A11 in proteoliposomes revealed that the protein catalyzes symport of one proton with one sulfate ion (net charge -1) coupled to antiport of one chloride ion (net charge -1), resulting in electroneutral exchange (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 1-4). This transport is strongly pH-dependent, with the highest sulfate accumulation observed at pH gradients of 2.0-2.5 units with the acidic pH on the extracellular (or luminal) side (kuhn2025slc26a11isan pages 1-4).
As a channel, SLC26A11 exhibits chloride-selective conductance that is gated by proton and sulfate transport (kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 18-20). Whole-cell patch clamp experiments demonstrated that SLC26A11 currents are activated by conditions favoring sulfate binding and transport, with current reversal potentials near the Nernst equilibrium potential for chloride (kuhn2025slc26a11isan pages 10-12, kuhn2025slc26a11isan pages 12-14). This dual functionality places SLC26A11 among a small group of transporters, including members of the SLC1 and ClC families, that exhibit both coupled transport and channel-like properties (kuhn2025slc26a11isan pages 14-16).
SLC26A11 transports multiple anions with varying affinities. Direct transport assays and competition studies identify the following substrates in order of effectiveness: sulfate (SO₄²⁻), oxalate (C₂O₄²⁻), thiosulfate, selenate, and chloride (Cl⁻), with weaker interactions with molybdate, iodide, and acetate (kuhn2025slc26a11isan pages 4-7, lee2024chloridemultipleanionexchanger pages 1-2). Bicarbonate and phosphate show minimal or no competition for the substrate binding site (kuhn2025slc26a11isan pages 4-7).
The apparent KM for sulfate transport is 39.7 ± 5.5 µM under optimal pH gradient conditions (pHout 5.0; pHin 7.5) (kuhn2025slc26a11isan pages 1-4). Substrate binding affinities are strongly pH-dependent: sulfate exhibits an apparent KD of 57 ± 11 µM at pH 5.0 versus 2.9 ± 0.4 mM at pH 7.5, representing nearly a 50-fold change, while chloride binding remains relatively constant at approximately 5-6 mM regardless of pH (kuhn2025slc26a11isan pages 10-12).
A unique feature of SLC26A11 is the presence of glutamate-320 (Glu-320), a residue not found at the equivalent position in other mammalian SLC26 family members (kuhn2025slc26a11isan pages 7-10, kuhn2025slc26a11isan pages 12-14). This residue acts as a pH-sensitive "signal integration node" that determines substrate preference (kuhn2025slc26a11isan pages 10-12, kuhn2025slc26a11isan pages 12-14).
Molecular dynamics simulations and differential scanning fluorimetry revealed that protonation of Glu-320 at acidic pH selectively increases sulfate binding affinity by approximately two orders of magnitude while leaving chloride affinity essentially unchanged (kuhn2025slc26a11isan pages 7-10, kuhn2025slc26a11isan pages 10-12). This mechanism is critical for SLC26A11's physiological function: in the acidic lysosomal lumen (pH ~4.6), protonated Glu-320 enables SLC26A11 to selectively bind sulfate despite the presence of 80-120 mM chloride that exceeds lysosomal sulfate concentrations by orders of magnitude (kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16).
Multiple independent lines of evidence from 2024 studies establish that SLC26A11 localizes predominantly to lysosomes in mammalian cells (bungertplumke2024oligomerizationandcellular pages 1-3, bungertplumke2024oligomerizationandcellular pages 3-5, kuhn2025slc26a11isan pages 1-4). Confocal microscopy experiments using fluorescently tagged SLC26A11 expressed in HEK293T cells, COS1 cells, CHO cells, and immortalized renal intercalated cells (Clone C) demonstrated exclusive intracellular localization with significant overlap with Lamp1, a lysosomal marker protein (Manders coefficient 0.45-0.50), and minimal overlap with the endoplasmic reticulum marker calnexin (Manders coefficient 0.09-0.12) (bungertplumke2024oligomerizationandcellular pages 1-3, bungertplumke2024oligomerizationandcellular pages 3-5).
This lysosomal localization is independent of cell type, protein expression level, or the presence of fluorescent protein tags (bungertplumke2024oligomerizationandcellular pages 1-3, bungertplumke2024oligomerizationandcellular pages 3-5). Both mouse and human SLC26A11 show similar intracellular distributions (bungertplumke2024oligomerizationandcellular pages 3-5). Importantly, proteomic and transcriptomic studies have independently identified SLC26A11 as a lysosomal membrane protein, and its expression is upregulated during lysosomal biogenesis (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14).
Although SLC26A11 is co-expressed with SLC26A4/pendrin and SLC26A7 in certain cell types, such as renal collecting duct intercalated cells, co-expression experiments and native gel electrophoresis demonstrated that SLC26A11 does not form heterodimers with SLC26A1, SLC26A2, SLC26A4, SLC26A6, SLC26A7, or SLC26A9 (bungertplumke2024oligomerizationandcellular pages 1-3, bungertplumke2024oligomerizationandcellular pages 3-5, bungertplumke2024oligomerizationandcellular pages 6-8). The protein functions exclusively as a homodimer, and heterodimerization does not alter its subcellular distribution (bungertplumke2024oligomerizationandcellular pages 3-5).
The structure of human SLC26A11 was determined by cryo-electron microscopy at 2.8 Å resolution in 2025, providing atomic-level insights into its mechanism (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10). SLC26A11 forms a homodimer with each protomer containing 14 transmembrane helices (TM1-14) arranged in two inverted repeats of seven TMs (kuhn2025slc26a11isan pages 7-10). The membrane domain is subdivided into a compact transport domain flanked by an elongated scaffold domain, with the two subdomains connected by α-helical interdomain linkers on both sides of the membrane (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10).
This architecture is shared with other SLC26 family members and related families (SLC4, SLC23), reflecting the conserved elevator-type transport mechanism characteristic of this superfamily (kuhn2025slc26a11isan pages 4-7, wang2021structureandfunction pages 1-2). However, SLC26A11 exhibits several unique structural features that distinguish it from other mammalian SLC26 proteins (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10).
Each protomer contains a C-terminal cytosolic STAS (Sulfate Transporter and Anti-Sigma factor antagonist) domain that is swapped between neighboring subunits in the dimer (kuhn2025slc26a11isan pages 4-7, wang2021structureandfunction pages 1-2). SLC26A11 has the most compact STAS domain of all human SLC26 transporters due to the absence of an internal intrinsically disordered "intervening sequence" and a comparatively short disordered C-terminus (kuhn2025slc26a11isan pages 7-10). The dimer interface is composed primarily of interactions between STAS domains and the scaffold domain elements (TM5, TM12, TM13, and the intracellular interdomain linker) (kuhn2025slc26a11isan pages 7-10).
The STAS domain plays a regulatory role in transport function. Studies of the related plant sulfate transporter AtSULTR4;1 demonstrated that deletion of the STAS domain or mutations at the STAS-transmembrane domain interface compromise dimer formation and reduce sulfate transport (wang2021structureandfunction pages 1-2).
Three structural deviations distinguish SLC26A11 from other mammalian SLC26 proteins (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10):
Alternative glycosylation site: While other human SLC26 isoforms carry glycosylation sites in the elongated extracellular loop TM3-4, SLC26A11 has a compact TM3-4 loop and instead features a β-hairpin extension in loop TM7-8 that carries an N-glycosylation site at Asn-294 (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10).
Kinked TM7 helix: TM7 in the scaffold domain is unusually long and kinked at Ala-246 within the membrane, creating a 107° angle between the extracellular and intracellular halves. This arrangement extends the intracellular loop TM6-7, which presents a potential class VIII SH3 domain binding sequence (PxxPxxP motif) that may mediate protein-protein interactions (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10, kuhn2025slc26a11isan pages 14-16).
Compact STAS domain: The absence of the intervening sequence found in other SLC26 proteins results in a smaller STAS domain with a reduced interface between adjacent STAS domains compared to other family members (kuhn2025slc26a11isan pages 7-10).
The primary physiological role of SLC26A11 is to function as the lysosomal sulfate exporter, a role that resolves a long-standing question in lysosomal biology (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16). Lysosomes are the primary degradative compartments of eukaryotic cells, and lysosomal recycling depends on the concerted action of hydrolases and transporters for catabolite export (kuhn2025slc26a11isan pages 1-4).
During lysosomal degradation, sulfur-containing macromolecules (amino acids, lipids, and glycosaminoglycans) are broken down, and sulfate groups are released by sulfatase enzymes (kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16). Accumulation of sulfate in the lysosomal lumen would cause competitive inhibition of sulfatases, impairing lysosomal function (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14). SLC26A11 mediates the export of sulfate from the lysosome using the proton gradient as a driving force, preventing product accumulation and maintaining optimal sulfatase activity (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 14-16).
The transport mechanism is well-suited to this function: at the acidic lysosomal pH (~4.6), Glu-320 is predominantly protonated, selectively increasing sulfate binding affinity and enabling sulfate-bound SLC26A11 to form despite high luminal chloride concentrations (80-120 mM) (kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16). After reorientation of the substrate binding site to the cytoplasm, the neutral pH leads to deprotonation of Glu-320, reducing sulfate affinity and promoting sulfate release (kuhn2025slc26a11isan pages 12-14).
The chloride channel activity of SLC26A11 may contribute to lysosomal chloride homeostasis (kuhn2025slc26a11isan pages 14-16). Since the Nernst potential for chloride in lysosomes is likely close to the membrane potential, chloride fluxes through the SLC26A11 channel are expected to be limited under physiological conditions (kuhn2025slc26a11isan pages 14-16). However, if luminal chloride concentrations exceed the range maintainable by the membrane potential, the chloride conductance may serve to decrease chloride levels, providing negative feedback that ensures high transport rates by accelerating the chloride-dependent transport mode (kuhn2025slc26a11isan pages 14-16).
While SLC26A11 in lysosomes serves a housekeeping function, plasmalemmal SLC26A11 has been implicated in pathological neuronal swelling and brain edema during ischemia (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16). Under physiological conditions at neutral pH and sub-millimolar extracellular sulfate concentrations, plasmalemmal SLC26A11 is unlikely to reach the chloride-conductive state (kuhn2025slc26a11isan pages 14-16). However, during brain trauma and ischemia, tissue acidification causes both external and internal pH to fall below 6.5, activating high SLC26A11 chloride currents that contribute to cytotoxic edema (kuhn2025slc26a11isan pages 14-16). This has led to proposals for SLC26A11 inhibition as a therapeutic strategy for ischemic stroke (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 14-16).
SLC26A11 exhibits broad tissue distribution, with highest expression in brain and additional expression in kidney (intercalated cells), pancreatic ducts, endothelial cells, and other tissues (kuhn2025slc26a11isan pages 1-4, lee2024chloridemultipleanionexchanger pages 1-2). This widespread expression pattern is consistent with a housekeeping role in lysosomal function across cell types (kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16). The protein's upregulation during lysosomal biogenesis further supports its essential role in lysosomal metabolism (kuhn2025slc26a11isan pages 1-4).
The SLC26 family comprises 11 members in mammals (SLC26A1-11, with A10 being a pseudogene) that function as anion exchangers or channels with diverse physiological roles (lee2024chloridemultipleanionexchanger pages 1-2). Family members share a common structural architecture but exhibit distinct substrate specificities, subcellular localizations, and tissue distributions (wang2021structureandfunction pages 1-2).
Other SLC26 members involved in sulfate homeostasis include:
SLC26A1 (Sat1): A plasma membrane sulfate/bicarbonate exchanger expressed in kidney, liver, and intestine that plays a major role in renal sulfate reabsorption and systemic sulfate homeostasis (pfau2023slc26a1isa pages 1-2). Loss-of-function mutations in human SLC26A1 cause hyposulfatemia and hypersulfaturia (pfau2023slc26a1isa pages 1-2).
SLC26A2 (DTDST): A sulfate transporter in chondrocytes essential for cartilage proteoglycan sulfation; mutations cause diastrophic dysplasia and other skeletal dysplasias (lee2024chloridemultipleanionexchanger pages 1-2).
The physiological importance of sulfate homeostasis has been increasingly recognized, with links to bone and cartilage health, intervertebral disc disorders, and musculoskeletal conditions (pfau2023slc26a1isa pages 1-2). SLC26A11's role as the lysosomal sulfate exporter complements the systemic sulfate homeostasis functions of SLC26A1 and the biosynthetic sulfate import functions of SLC26A2.
| Functional Category | Key Information | Evidence Source |
|---|---|---|
| Primary Function | A0A2R9CAF4 from Pan paniscus is best interpreted as the bonobo ortholog of SLC26A11, a sodium-independent sulfate anion transporter in the SLC26/SulP family. Recent mechanistic work identifies SLC26A11 as the lysosomal sulfate exporter and a dual-function protein capable of both coupled sulfate transport and chloride conductance. | (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14) |
| Substrate Specificity | Direct functional studies show transport or strong competition by sulfate, chloride, oxalate, thiosulfate, selenate, and molybdate; iodide, acetate, and chloride inhibit sulfate uptake to lesser extents, while phosphate and bicarbonate show little to no effect in the reconstituted assay. Earlier family summaries also list Cl−, HCO3−, SO4^2−, and oxalate for SLC26A11/KBAT. | (kuhn2025slc26a11isan pages 4-7, lee2024chloridemultipleanionexchanger pages 1-2) |
| Transport Mechanism | SLC26A11 operates primarily as an electroneutral proton:sulfate/chloride exchanger. The most parsimonious model is symport of 1 H+ with 1 SO4^2− coupled to antiport of 1 Cl−. Independent electrophysiology further shows a chloride-selective channel-like conductance gated by proton/sulfate transport, establishing dual transporter-channel behavior. | (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 12-14) |
| Kinetic Parameters | Apparent sulfate transport KM in proteoliposomes: 39.7 ± 5.5 µM under a strong pH gradient (pHout 5.0; pHin 7.5). Apparent KD values from DSF: chloride 6.0 ± 1.4 mM at pH 5.0 and 5.3 ± 0.7 mM at pH 7.5; sulfate 57 ± 11 µM at pH 5.0 versus 2.9 ± 0.4 mM at pH 7.5, showing strong pH-dependent sulfate selectivity. | (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 10-12) |
| Subcellular Localization | In mammalian cells, SLC26A11 localizes predominantly to lysosomes, with significant overlap with Lamp1 and minimal overlap with the ER marker calnexin. Co-expression with SLC26A4 or SLC26A7 does not relocalize it, and no evidence for heterodimerization with those paralogs was found. A fraction reaches the plasma membrane in Sf9 insect cells, enabling electrophysiology, but lysosomal localization is the dominant mammalian pattern. | (bungertplumke2024oligomerizationandcellular pages 1-3, bungertplumke2024oligomerizationandcellular pages 3-5, bungertplumke2024oligomerizationandcellular pages 6-8, kuhn2025slc26a11isan pages 10-12) |
| Structural Features | SLC26A11 forms a homodimer. Each protomer contains 14 transmembrane helices organized into transport and scaffold domains plus a cytosolic STAS domain. The STAS domains are domain-swapped between protomers. SLC26A11 has a notably compact STAS domain, an alternative N-glycosylation site at Asn-294 in the TM7-8 loop, and a kinked TM7 that exposes a potential SH3-binding motif. | (kuhn2025slc26a11isan pages 4-7, kuhn2025slc26a11isan pages 7-10) |
| Biological Processes | The transporter participates in lysosomal sulfate homeostasis and catabolite clearance. Sulfate produced by lysosomal degradation and sulfatase reactions must be exported to prevent product accumulation and competitive inhibition of sulfatases; SLC26A11 is proposed to mediate this efflux using the lysosomal proton gradient. It is also discussed as contributing to lysosomal chloride homeostasis and transport-rate optimization. | (kuhn2025slc26a11isan pages 1-4, kuhn2025slc26a11isan pages 12-14, kuhn2025slc26a11isan pages 14-16) |
| Tissue Expression | SLC26A11 is broadly expressed, with highest reported expression in brain and additional expression in kidney/intercalated cells, pancreatic ducts, endothelial cells, and other tissues. Broad distribution is consistent with a housekeeping role in lysosomal function. | (kuhn2025slc26a11isan pages 1-4, lee2024chloridemultipleanionexchanger pages 1-2, kuhn2025slc26a11isan pages 12-14) |
| Unique Features | A distinctive Glu-320 residue, unique among mammalian SLC26 family members at the aligned position, acts as a pH-sensitive determinant of substrate preference. Protonation of Glu-320 selectively increases sulfate affinity by nearly two orders of magnitude while leaving chloride affinity largely unchanged, explaining how SLC26A11 favors sulfate export from the acidic lysosomal lumen despite high luminal chloride. | (kuhn2025slc26a11isan pages 7-10, kuhn2025slc26a11isan pages 10-12, kuhn2025slc26a11isan pages 12-14) |
| Clinical Relevance | SLC26A11 chloride currents have been implicated in pathological neuronal swelling and ischemia-associated brain edema under acidic conditions, making SLC26A11 a potential therapeutic target. More broadly, recent sulfate-transporter work in related SLC26 members underscores the physiological importance of sulfate homeostasis in humans, including musculoskeletal and cartilage biology, which strengthens interest in SLC26A11 as a lysosomal sulfate-handling protein. | (kuhn2025slc26a11isan pages 14-16, pfau2023slc26a1isa pages 1-2) |
Table: This table summarizes the current functional annotation for bonobo A0A2R9CAF4 as the SLC26A11 ortholog, integrating recent structural, mechanistic, localization, and clinical evidence. It is useful for quickly mapping primary function, substrate handling, localization, and biological significance to specific cited sources.
While no direct studies exist for the bonobo protein A0A2R9CAF4, the high conservation of SLC26A11 orthologs and the comprehensive mechanistic understanding derived from recent human studies (2024-2025) allow confident functional annotation. The protein functions primarily as the lysosomal sulfate exporter, utilizing an elegant pH-sensing mechanism via Glu-320 to selectively transport sulfate from the acidic lysosomal lumen despite high competing chloride concentrations. Its dual transporter-channel function represents a sophisticated regulatory mechanism linking sulfate export to chloride homeostasis.
The identification of SLC26A11's lysosomal function has implications for understanding lysosomal storage diseases and may provide new therapeutic approaches. Additionally, its role in pathological brain edema suggests potential for therapeutic intervention in ischemic stroke through specific SLC26A11 inhibition (kuhn2025slc26a11isan pages 14-16).
References
(kuhn2025slc26a11isan pages 1-4): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(bungertplumke2024oligomerizationandcellular pages 1-3): Stefanie Bungert-Plümke, Raul E. Guzman, and Christoph Fahlke. Oligomerization and cellular localization of slc26a11. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.04.29.591613, doi:10.1101/2024.04.29.591613. This article has 2 citations.
(lee2024chloridemultipleanionexchanger pages 1-2): Dongun Lee and Jeong Hee Hong. Chloride/multiple anion exchanger slc26a family: systemic roles of slc26a4 in various organs. International Journal of Molecular Sciences, 25:4190, Apr 2024. URL: https://doi.org/10.3390/ijms25084190, doi:10.3390/ijms25084190. This article has 10 citations.
(kuhn2025slc26a11isan pages 12-14): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(kuhn2025slc26a11isan pages 4-7): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(kuhn2025slc26a11isan pages 18-20): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(kuhn2025slc26a11isan pages 10-12): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(kuhn2025slc26a11isan pages 14-16): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(kuhn2025slc26a11isan pages 7-10): Benedikt T Kuhn, Peter Kovermann, Bassam G Haddad, Tim Rasmussen, Tamsanga Hove, Stefanie Bungert-Pluemke, Bettina Boettcher, Jan-Philipp Machtens, Christoph Fahlke, and Eric R. Geertsma. Slc26a11 is an atypical solute carrier with dual transport-channel function mediating lysosomal sulfate transport. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.17.670773, doi:10.1101/2025.08.17.670773. This article has 1 citations.
(bungertplumke2024oligomerizationandcellular pages 3-5): Stefanie Bungert-Plümke, Raul E. Guzman, and Christoph Fahlke. Oligomerization and cellular localization of slc26a11. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.04.29.591613, doi:10.1101/2024.04.29.591613. This article has 2 citations.
(bungertplumke2024oligomerizationandcellular pages 6-8): Stefanie Bungert-Plümke, Raul E. Guzman, and Christoph Fahlke. Oligomerization and cellular localization of slc26a11. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.04.29.591613, doi:10.1101/2024.04.29.591613. This article has 2 citations.
(wang2021structureandfunction pages 1-2): Lie Wang, Kehan Chen, and Ming Zhou. Structure and function of an arabidopsis thaliana sulfate transporter. Nature Communications, Jul 2021. URL: https://doi.org/10.1038/s41467-021-24778-2, doi:10.1038/s41467-021-24778-2. This article has 77 citations and is from a highest quality peer-reviewed journal.
(pfau2023slc26a1isa pages 1-2): Anja Pfau, Karen I. López-Cayuqueo, Nora Scherer, Matthias Wuttke, Annekatrin Wernstedt, Daniela González Fassrainer, Desiree E.C. Smith, Jiddeke M. van de Kamp, Katharina Ziegeler, Kai-Uwe Eckardt, Friedrich C. Luft, Peter S. Aronson, Anna Köttgen, Thomas J. Jentsch, and Felix Knauf. Slc26a1 is a major determinant of sulfate homeostasis in humans. The Journal of Clinical Investigation, Feb 2023. URL: https://doi.org/10.1172/jci161849, doi:10.1172/jci161849. This article has 21 citations.